Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia.
暂无分享,去创建一个
David A Lewis | Takanori Hashimoto | Stephen M Eggan | D. Lewis | T. Hashimoto | S. Eggan | D. Lewis
[1] J. Negrete,et al. Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey , 1986, Psychological Medicine.
[2] T. Sawaguchi,et al. Delayed response deficit in monkeys by locally disturbed prefrontal neuronal activity by bicuculline , 1988, Behavioural Brain Research.
[3] M. Herkenham,et al. Cannabinoid receptor localization in brain. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[4] D. Lewis,et al. Cholecystokinin innervation of monkey prefrontal cortex:An immunohistochemical study , 1990, The Journal of comparative neurology.
[5] W. Slikker,et al. Chronic exposure toΔ9-tetrahydrocannabinol fails to irreversibly alter brain cannabinoid receptors , 1991, Brain Research.
[6] M. Herkenham,et al. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[7] M. Herkenham,et al. Cannabinoid receptor binding and messenger RNA expression in human brain: An in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains , 1994, Neuroscience.
[8] P. Massi,et al. Chronic CP-55,940 alters cannabinoid receptor mRNA in the rat brain: an in situ hybridization study. , 1994, Neuroreport.
[9] P S Goldman-Rakic,et al. Cytoarchitectonic definition of prefrontal areas in the normal human cortex: I. Remapping of areas 9 and 46 using quantitative criteria. , 1995, Cerebral cortex.
[10] E. G. Jones,et al. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. , 1995, Archives of general psychiatry.
[11] R. Faull,et al. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain , 1997, Neuroscience.
[12] R. Hampson,et al. Effects of long-term exposure to Δ9-THC on expression of cannabinoid receptor (CB1) mRNA in different rat brain regions , 1998 .
[13] R. Hampson,et al. Effects of long-term exposure to delta9-THC on expression of cannabinoid receptor (CB1) mRNA in different rat brain regions. , 1998, Brain research. Molecular brain research.
[14] J. Manzanares,et al. Time‐course of the cannabinoid receptor down‐regulation in the adult rat brain caused by repeated exposure to Δ9‐tetrahydrocannabinol , 1998, Synapse.
[15] J. M. Moerschbaecher,et al. Cannabinoid ligands and their effects on learning and performance in rhesus monkeys. , 1999, Behavioural pharmacology.
[16] J. Pierri,et al. Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects. , 1999, The American journal of psychiatry.
[17] J. Ramos,et al. Cannabinoid receptor binding and mRNA levels in several brain regions of adult male and female rats perinatally exposed to delta9-tetrahydrocannabinol. , 1999, Drug and alcohol dependence.
[18] H. Emrich,et al. Elevated endogenous cannabinoids in schizophrenia. , 1999, Neuroreport.
[19] G. Marsicano,et al. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain , 1999, The European journal of neuroscience.
[20] A. Sampson,et al. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. , 2000, Archives of general psychiatry.
[21] P. Goldman-Rakic,et al. Destruction and Creation of Spatial Tuning by Disinhibition: GABAA Blockade of Prefrontal Cortical Neurons Engaged by Working Memory , 2000, The Journal of Neuroscience.
[22] I. Módy,et al. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations , 2000, The European journal of neuroscience.
[23] L. Glantz,et al. Normal cellular levels of synaptophysin mRNA expression in the prefrontal cortex of subjects with schizophrenia , 2000, Biological Psychiatry.
[24] T. Goldberg,et al. Cognitive impairment in schizophrenia is the core of the disorder. , 2000, Critical reviews in neurobiology.
[25] P. Massi,et al. Changes in the Cannabinoid Receptor Binding, G Protein Coupling, and Cyclic AMP Cascade in the CNS of Rats Tolerant to and Dependent on the Synthetic Cannabinoid Compound CP55,940 , 2000, Journal of neurochemistry.
[26] Yogesh K. Dwivedi,et al. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. , 2000, Archives of general psychiatry.
[27] T. Freund,et al. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus , 2001, Neuroscience.
[28] M. Egan,et al. Prefrontal neurons and the genetics of schizophrenia , 2001, Biological Psychiatry.
[29] C. Breivogel,et al. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. , 2001, Molecular pharmacology.
[30] B. Dean,et al. Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use , 2001, Neuroscience.
[31] P. Somogyi,et al. Input‐dependent synaptic targeting of α2‐subunit‐containing GABAA receptors in synapses of hippocampal pyramidal cells of the rat , 2001, The European journal of neuroscience.
[32] D. Parolaro,et al. Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levels. , 2002, Drug and alcohol dependence.
[33] Thomas Babor,et al. Cognitive functioning of long-term heavy cannabis users seeking treatment. , 2002, JAMA.
[34] M. Kano,et al. Presynaptic Cannabinoid Sensitivity Is a Major Determinant of Depolarization-Induced Retrograde Suppression at Hippocampal Synapses , 2002, The Journal of Neuroscience.
[35] A. Sampson,et al. Gene Expression Deficits in a Subclass of GABA Neurons in the Prefrontal Cortex of Subjects with Schizophrenia , 2003, The Journal of Neuroscience.
[36] Michael Koch,et al. Chronic Pubertal, but not Adult Chronic Cannabinoid Treatment Impairs Sensorimotor Gating, Recognition Memory, and the Performance in a Progressive Ratio Task in Adult Rats , 2003, Neuropsychopharmacology.
[37] L. Petrocellis,et al. Endocannabinoid signalling in the blood of patients with schizophrenia , 2003, Lipids in Health and Disease.
[38] D. Lewis,et al. Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction , 2004, Psychopharmacology.
[39] T. Freund,et al. Role of endogenous cannabinoids in synaptic signaling. , 2003, Physiological reviews.
[40] Y. Hurd,et al. Preferential limbic expression of the cannabinoid receptor mRNA in the human fetal brain , 2003, Neuroscience.
[41] Marc W Howard,et al. Gamma oscillations correlate with working memory load in humans. , 2003, Cerebral cortex.
[42] Joachim Klosterkötter,et al. Cerebrospinal Anandamide Levels are Elevated in Acute Schizophrenia and are Inversely Correlated with Psychotic Symptoms , 2004, Neuropsychopharmacology.
[43] Huda Akil,et al. Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. , 2004, Human molecular genetics.
[44] J. Manzanares,et al. Chronic ethanol consumption regulates cannabinoid CB1 receptor gene expression in selected regions of rat brain. , 2004, Alcohol and alcoholism.
[45] Ralitza Gueorguieva,et al. The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis , 2004, Neuropsychopharmacology.
[46] Therese Garrick,et al. Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia , 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[47] John R. Huguenard,et al. Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids , 2004, Nature.
[48] S. Hestrin,et al. Electrical Coupling among Irregular-Spiking GABAergic Interneurons Expressing Cannabinoid Receptors , 2004, The Journal of Neuroscience.
[49] B. Alger,et al. Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus , 2004, Nature Neuroscience.
[50] D. Lewis,et al. Cortical inhibitory neurons and schizophrenia , 2005, Nature Reviews Neuroscience.
[51] Peter B. Jones,et al. Cannabis use and outcome of recent onset psychosis , 2005, European Psychiatry.
[52] Judit K. Makara,et al. Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus , 2005, Nature Neuroscience.
[53] A. Christopoulos,et al. Allosteric Modulation of the Cannabinoid CB1 Receptor , 2005, Molecular Pharmacology.
[54] Ken Mackie,et al. Endocannabinoid Signaling in Rat Somatosensory Cortex: Laminar Differences and Involvement of Specific Interneuron Types , 2005, The Journal of Neuroscience.
[55] A. Sampson,et al. Relationship of Brain-Derived Neurotrophic Factor and Its Receptor TrkB to Altered Inhibitory Prefrontal Circuitry in Schizophrenia , 2005, The Journal of Neuroscience.
[56] Ralitza Gueorguieva,et al. Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction , 2005, Biological Psychiatry.
[57] R. Murray,et al. The environment and schizophrenia: the role of cannabis use. , 2005, Schizophrenia bulletin.
[58] David A Lewis,et al. GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia. , 2005, Current neuropharmacology.
[59] J. Addington,et al. Outcome of a first episode of psychosis in adolescence: a 2-year follow-up , 2005, Psychiatry Research.
[60] Zhuoxin Sun,et al. The Influence of Chronic Exposure to Antipsychotic Medications on Brain Size before and after Tissue Fixation: A Comparison of Haloperidol and Olanzapine in Macaque Monkeys , 2005, Neuropsychopharmacology.
[61] T. Freund,et al. Molecular Composition of the Endocannabinoid System at Glutamatergic Synapses , 2006, The Journal of Neuroscience.
[62] Vivien Chevaleyre,et al. Endocannabinoid-mediated synaptic plasticity in the CNS. , 2006, Annual review of neuroscience.
[63] Carol A. Tamminga,et al. Human postmortem tissue: What quality markers matter? , 2006, Brain Research.
[64] Bruce L McNaughton,et al. Cannabinoids reveal importance of spike timing coordination in hippocampal function , 2006, Nature Neuroscience.
[65] C. Carter,et al. Impairments in frontal cortical γ synchrony and cognitive control in schizophrenia , 2006, Proceedings of the National Academy of Sciences.
[66] C. Carter,et al. Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[67] Xu-Feng Huang,et al. Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia , 2006, Experimental Brain Research.
[68] Masahiko Watanabe,et al. The CB1 Cannabinoid Receptor Is the Major Cannabinoid Receptor at Excitatory Presynaptic Sites in the Hippocampus and Cerebellum , 2006, The Journal of Neuroscience.
[69] Michael B. Mayhew,et al. Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression , 2007, Molecular Psychiatry.
[70] M. Kano,et al. Presynaptic Monoacylglycerol Lipase Activity Determines Basal Endocannabinoid Tone and Terminates Retrograde Endocannabinoid Signaling in the Hippocampus , 2007, The Journal of Neuroscience.
[71] Peter B. Jones,et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review , 2007, The Lancet.
[72] David A Lewis,et al. Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis. , 2006, Cerebral cortex.
[73] Edward O. Mann,et al. Role of GABAergic inhibition in hippocampal network oscillations , 2007, Trends in Neurosciences.
[74] I. Soltesz,et al. Cell type–specific gating of perisomatic inhibition by cholecystokinin , 2007, Nature Neuroscience.
[75] B. Kocsis,et al. Activation of Cannabinoid-1 Receptors Disrupts Sensory Gating and Neuronal Oscillation: Relevance to Schizophrenia , 2008, Biological Psychiatry.
[76] H. M. Morris,et al. Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia , 2008, Molecular Psychiatry.